Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.

Stanciu AE, Serdarevic N, Hurduc AE, Stanciu MM.

Scand J Clin Lab Invest. 2015 Nov;75(7):539-48. doi: 10.3109/00365513.2015.1057895. Epub 2015 Jul 25.

PMID:
26305420
2.

Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?

Divani SN, Kalodimos GP, Lioupis MA, Syrmos NC.

Hell J Nucl Med. 2016 Sep-Dec;19(3):250-253. doi: 10.1967/s002449910408. Epub 2016 Nov 8.

3.

Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.

Liang J, Zeng W, Fang F, Yu T, Zhao Y, Fan X, Guo N, Gao X.

Acta Otorhinolaryngol Ital. 2017 Oct;37(5):393-400. doi: 10.14639/0392-100X-1709.

4.

Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.

Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S, Zhang J.

Otolaryngol Head Neck Surg. 2013 Mar;148(3):396-402. doi: 10.1177/0194599812472426. Epub 2013 Jan 8.

PMID:
23300224
5.

Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.

Latrofa F, Ricci D, Montanelli L, Rocchi R, Piaggi P, Sisti E, Grasso L, Basolo F, Ugolini C, Pinchera A, Vitti P.

J Clin Endocrinol Metab. 2012 Jul;97(7):2380-7. doi: 10.1210/jc.2011-2812. Epub 2012 Apr 26.

PMID:
22539585
6.

Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.

Huang BY, Hseuh C, Chao TC, Lin KJ, Lin JD.

Endocr Pathol. 2011 Sep;22(3):144-9. doi: 10.1007/s12022-011-9164-9.

PMID:
21647844
7.

[Assessment of 25(OH)D3, concentration levels in patients with papillary thyroid cancer compared to patients with Hashimoto's thyroiditis].

Lizis-Kolus K, Hubalewska-Dydejczyk A, Trofimiuk-Muldnerz M, Sowa-Staszczak A, Kowalska A.

Przegl Lek. 2013;70(11):920-5. Polish.

PMID:
24697030
8.

Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.

Song E, Jeon MJ, Park S, Kim M, Oh HS, Song DE, Kim WG, Kim WB, Shong YK, Kim TY.

Clin Endocrinol (Oxf). 2018 Jan;88(1):123-128. doi: 10.1111/cen.13475. Epub 2017 Oct 4.

PMID:
28906015
9.

The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.

Zhang Y, Dai J, Wu T, Yang N, Yin Z.

J Cancer Res Clin Oncol. 2014 Jun;140(6):1021-6. doi: 10.1007/s00432-014-1629-z. Epub 2014 Mar 12.

PMID:
24619663
10.

The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.

Zhang L, Li H, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y.

BMC Cancer. 2012 Dec 21;12:610. doi: 10.1186/1471-2407-12-610.

11.

High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.

Dong S, Xia Q, Wu YJ.

Otolaryngol Head Neck Surg. 2015 Jul;153(1):20-6. doi: 10.1177/0194599815581831. Epub 2015 Apr 27.

PMID:
25917667
12.

Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.

Baser H, Ozdemir D, Cuhaci N, Aydin C, Ersoy R, Kilicarslan A, Cakir B.

Endocr Pathol. 2015 Dec;26(4):356-64. doi: 10.1007/s12022-015-9401-8.

PMID:
26481630
13.

Clinical Relationship Between IgG4-Positive Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma.

Yu Y, Zhang J, Lu G, Li T, Zhang Y, Yu N, Gao Y, Gao Y, Guo X.

J Clin Endocrinol Metab. 2016 Apr;101(4):1516-24. doi: 10.1210/jc.2015-3783. Epub 2016 Feb 11.

PMID:
26866571
14.

Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.

Hirokawa M, Nishihara E, Takada N, Higuchi M, Kotakemori M, Hayashi T, Miyauchi A.

Endocr J. 2018 Feb 26;65(2):175-180. doi: 10.1507/endocrj.EJ17-0319. Epub 2017 Nov 2.

15.

[Diagnosis and surgical treatment of Hashimoto's thyroiditis complicated with papillary thyroid carcinoma (with 51 cases of clinical analysis)].

Chen J, Wang J.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Mar;24(6):257-60. Chinese.

PMID:
20518289
16.
17.

Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.

Kim SJ, Myong JP, Jee HG, Chai YJ, Choi JY, Min HS, Lee KE, Youn YK.

Head Neck. 2016 Jan;38(1):95-101. doi: 10.1002/hed.23854. Epub 2015 Jun 26.

PMID:
25213729
18.

[Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].

Xu DD, Lun Y, Liu X, Jiang H, Song JB, Duan ZQ, Xin SJ, Zhang J.

Zhonghua Yi Xue Za Zhi. 2017 Aug 22;97(32):2491-2495. doi: 10.3760/cma.j.issn.0376-2491.2017.32.004. Chinese.

PMID:
28835054
19.

Osteopontin levels in patients with papillary thyroid cancer according to the presence of Hashimoto's thyroiditis.

Park SH, Park CS, Kim YI, Nam-Goong IS, Kim YS, Lee JC, Choi JI, Park JW, Kim ES.

Asian Pac J Cancer Prev. 2015;16(6):2447-51.

20.

Supplemental Content

Support Center